Ana Đurić (Ana Djuric)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Breast Cancer Cells

Histone Deacetylase

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Marija Ostojić, Ana Đurić, Kristina Živić, Jelena Grahovac
Analysis of the nischarin expression across human tumor types reveals its context-dependent role and a potential as a target for drug repurposing in oncology. PloS one 19 (5) (2024)
Marija Ostojić, Ana Đurić, Kristina Živić, Jelena Grahovac
Analysis of the nischarin expression across human tumor types reveals its context-dependent role and a potential as a target for drug repurposing in oncology. PloS one 19 (5) (2024)
Marija Ostojić, Ana Đurić, Kristina Živić, Jelena Grahovac
Analysis of the nischarin expression across human tumor types reveals its context-dependent role and a potential as a target for drug repurposing in oncology. PloS one 19 (5) (2024)
Nemanja Djokovic, Ana Đurić, Dusan Ruzic, Tatjana Srdic-Rajic, Katarina Nikolic
Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)